[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biosimilars Market Research Reports & Industry Analysis

Biosimilars (otherwise termed follow-on-biologics, or FOBs for short) stand for the versions of biopharmaceuticals, which have the resembling but not identical parent molecule, and are created either by living organisms or from living micro-organisms by way of rDNA (recombinant DNA) or supervised gene expression technologies. The approval of Biosimilars occurs via strictly defined regulatory paths based on whether FOBs have shown comparability with their reference substance.

The worldwide Biosimilars Market is anticipated to surpass a EUR 14.9bn mark by end 2018. The major drivers encompass cost efficiency of biosimilars versus their high-priced analogues, the enlarging thirst for biotechnology drugs, imminent biotech drugs’ patent expiries, the planet’s aging population, and the rising frequency of critical illnesses. The illustrious actors on the global Biosimilars stage encompass Biocon, Intas Biopharmaceuticals, Cipla, Biopartners, Hospira, Wockhardt, Teva Pharmaceutical Industries, Sandoz International, amidst others.

The Catalogue’s research reports offer world, region and nation-wise analyses of the Biosimilars Market development over various time periods. The researches are lavish with discussions of the Biosimilars Industry growth rate, structure and capacity. The market trends, growth obstacles/stimulators, key products and those in R&D stage, and more issues are studied in the reports. Additionally, the research reports indicate and profile the leading players and hoped-for entrants, and offer market projections and forecasts.

Publications found: 176
Sort by:
Adalimumab - Biosimilars Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Adalimumab – Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 45+ marketed an...

August 2020 90 pages
Bevacizumab - Biosimilars Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 96-120 hours DelveInsight’s, “Bevacizumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 40+ companies and 40+ marketed a...

August 2020 125 pages
Filgrastim - Biosimilar Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Filgrastim– Biosimilar Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+ marketed and...

August 2020 70 pages
Infliximab - Biosimilars Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Infliximab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 45+ marketed and...

August 2020 90 pages
Insulin Glargine- Biosimilar Insight, 2020 US$ 2,000.00

This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Insulin Glargine– Biosimilar Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ market...

August 2020 90 pages
Interferon - Biosimilar Insight, 2020 US$ 1,000.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Interferon– Biosimilar Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ marketed and...

August 2020 70 pages
Ranibizumab - Biosimilars Insight, 2020 US$ 1,500.00

This report can be delivered to the clients within 72-96 hours DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+ marketed an...

August 2020 90 pages
Rituximab - Biosimilars Insight, 2020 US$ 2,500.00

This report can be delivered to the clients within 96-120 hours DelveInsight’s, “Rituximab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 35+ marketed and...

August 2020 125 pages
Somatotropin - Biosimilar Insight, 2020 US$ 1,000.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Somatropin – Biosimilar Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+ marketed an...

August 2020 70 pages
Trastuzumab - Biosimilars Insight, 2020 US$ 2,500.00

This report can be delivered to the clients within 96-120 hours DelveInsight’s, “Trastuzumab– Biosimilar Insight, 2020,” report provides comprehensive insights about 35+ companies and 35+ marketed a...

August 2020 125 pages
Global Biosimilars - Market and Technology Forecast to 2028 US$ 3,995.00

Biosimilars have a very complex molecular structure and they have similar characteristics as compared to their reference medicine. Biosimilars are mainly used to derive known effective medicinal produ...

June 2020 256 pages
Global Biosimilar Monoclonal Antibody Market Size study, by Type (Synthetic Chemicals, Biopharmaceuticals and Others), By Application (Chronic & Autoimmune Diseases, Oncology and Others) and Regional Forecasts 2019-2026 US$ 4,950.00

Global Biosimilar Monoclonal Antibody Market is valued approximately at USD 27.84 Billion in 2018 and is anticipated to grow with a healthy growth rate of more than 35.70% over the forecast period 201...

April 2020 200 pages
Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region – Global Forecast to 2025 US$ 5,650.00

... the forecast period.” The biosimilars market by product, is categorized into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant glycosylated proteins segment is expected ...

March 2020 187 pages
Biosimilars in Immunology US$ 5,597.00

Biosimilars in Immunology SUMMARY 'GlobalData’s Biosimilars in Immunology Thematic Analysis report combines key opinion leader insight and interviews with payers in the US, France, Germany, Italy, S...

February 2020 137 pages
Japan Biosimilars- Landscape Today Outlook Tomorrow US$ 4,500.00

“Biosame” entry, uninterrupted supply and companies’ strong front-end footprint requirement makes it distinctAfter a decade, JP Biosimilar guideline’s first revision expected in FY2020 –Demonstrate Ch...

January 2020 156 pages
Asia Pacific Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes), By Country (Japan, China, India, South Korea, Bangladesh, Pakistan), Competition, Forecast & Opportunities, 2024 US$ 3,950.00

Biosimilar is a biological product which is similar to the reference product, already approved by authorities and marketed by companies other than the patent holder company. Insulin is a hormone produ...

January 2020 93 pages
Europe Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024 US$ 3,950.00

Europe biosimilar insulin glargine and lispro market is projected to reach $ 1.9 billion by 2024 owing to rising levels of obesity, growing expenditure on healthcare and increasing adoption of sedenta...

January 2020 86 pages
The 2021-2026 World Outlook for 3D Printing Powders US$ 995.00

This study covers the world outlook for 3D printing powders across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for 3D printing powders. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...

November 2019 299 pages
Global Biosimilars Market – Products, Applications and Regulations US$ 4,050.00

... patients, etc. Monoclonal Antibodies constitute the single largest product type in the global Biosimilars market, demand for which is estimated at US$4.4 billion in 2018 and is projected ...

May 2019 364 pages
US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 US$ 2,400.00

... Phase: 28 Biosimilars Marketed Biosimilars Clinical Insight by Company & Indication: 9 Biosimilars Biosimilars Market Opportunity: US$ 5 Billion FDA Rules & Regulations For Biosimilars Development & Market Approved & Marketed Biosimilars: Clinical Insight, Price & Dosage 'US Biosimilars Market, Dosage, Price ...

March 2019 300 pages
Global G-CSF Biosimilars Market Size study, by Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies) and Regional Forecasts 2018-2025 US$ 3,950.00

... – 2018 to 2025 Target Audience of the Global G-CSF Biosimilars Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...

February 2019 200 pages
Biosimilars: Market Research Report US$ 5,450.00

This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary ...

January 2019 243 pages
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics US$ 2,396.00

Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics SUMMARY GBI Research’s latest report: “Biosimilars” provides an in-depth ...

January 2019 108 pages
ASEAN and China Biosimilars Market by Molecule Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibody, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, and Peptide), and Application (Blood Disorder, Oncology Disease, Chronic & Autoimmune Disease, Growth Hormone Deficiency, and Others): Opportunity Analysis and Industry Forecast, 2017 - 2025 US$ 3,200.00

... the expansion of the biosimilars market across ASEAN and China. The ASEAN and China biosimilars market is segmented into molecule ... market is analyzed across China and ASEAN region. Key Benefits ASEAN and China Biosimilars Market: The study provides an in-depth analysis of the ASEAN and China biosimilars market ...

November 2018 130 pages
Global Biologics and Biosimilars Industry Market Research 2018 US$ 2,600.00

... Biologics and Biosimilars market challenges to market growth? 10. What are the Biologics and Biosimilars market opportunities and threats faced by the vendors in the global Biologics and Biosimilars ...

September 2018 158 pages
Biosimilars: US Payer Perspectives (2018) US$ 2,495.00

... 2018). You won't find entrenched perceptions, old data and out-of-date opinions. Instead, Biosimilars: US Payer Perspectives ... Example insight included in Biosimilars: US Payer Perspectives Payers have devised strategies to encourage the adoption of biosimilars. Currently, payers require prior authorisations, ...

March 2018
Global Biosimilars Market 2018-2024 US$ 3,000.00

... the growth this market to a large extent. Market Analysis: The “Global Biosimilars Market” is estimated to witness a CAGR of 57.03% during the forecast period 2018–2024. The market is analyzed based on three ...

March 2018 120 pages
Biosimilars: Global Markets US$ 2,125.00

... emerging framework in regulated markets, as well as comparisons of biosimilar guidelines in Europe, the U.S., Japan, Canada, as well the guidelines developed by the - World Health Organization Technology trends and ...

March 2018 340 pages
Biosimilars-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilars market as: Asia Pacific Biosimilars Market ...

February 2018 150 pages
Biosimilars-China Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the China Biosimilars market as: China Biosimilars Market: Regional ...

February 2018 141 pages
Biosimilars-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Biosimilars-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...

February 2018 146 pages
Biosimilars-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilars market as: Europe Biosimilars Market: Regional ...

February 2018 137 pages
Biosimilars-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... Summary Biosimilars-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data in Global ...

February 2018 138 pages
Biosimilars-Global Market Status and Trend Report 2013-2023 US$ 2,480.00

Report Summary Biosimilars-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...

February 2018 153 pages
Biosimilars-India Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the India Biosimilars market as: India Biosimilars Market: Regional ...

February 2018 144 pages
Biosimilars-North America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the North America Biosimilars market as: North America Biosimilars Market ...

February 2018 132 pages
Biosimilars-South America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the South America Biosimilars market as: South America Biosimilars Market ...

February 2018 135 pages
Biosimilars-United States Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the United States Biosimilars market as: United States Biosimilars Market ...

February 2018 140 pages
Biosimilars: EU Payer Perspectives US$ 2,495.00

... relation to Humira biosimilars Future challenges and opportunities in the European biosimilars market Example insight included in Biosimilars: EU Payer Perspectives 'Aligned with ... been hugely successful.' Example quote included in Biosimilars: EU Payer Perspectives 'There have been huge cost savings over ...

January 2018
Biosimilars Market, 2012 to 2023 US$ 4,400.00

... , Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Global Biosimilars Market Report Description: Global biosimilars market report gives a comprehensive outlook on biosimilars products across the ...

January 2018 192 pages
Charting the Global Biosimialr pipeline US$ 745.00

... and many other questions can be found in Charting the Global Biosimilars Pipeline. This comprehensive report provides the most detailed evaluation ... biosimilar companies Biosimilar pipeline by product BIOSIMILAR PIPELINE BY PRODUCT Each biosimilar monograph utilises well-structured tables and charts to provide ...

December 2017
Biosimilar Insulin-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilar Insulin market as: Asia Pacific Biosimilar Insulin Market ...

December 2017 135 pages
Biosimilar Insulin-China Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the China Biosimilar Insulin market as: China Biosimilar Insulin Market ...

December 2017 132 pages
Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data and ...

December 2017 135 pages
Biosimilar Insulin-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilar Insulin market as: Europe Biosimilar Insulin Market ...

December 2017 132 pages
Biosimilar Insulin-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... Biosimilar Insulin-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data in Global ...

December 2017 132 pages

Filters

Search

Publishers

10
1
3
2
1
1
2
1
1
2
1
1
40
1
3
1
1
1
2
1
5
1
1
1
1
1
2
1
2
8
1
10
8
31
21
2
3
1

Regions

5
4
4
5
7
1
5
6
7
132

Price

Date

Pages

Offers

1
1